Vaddi Krishna
Insider CIK 1824633 · PRLD President, CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-02-04 | 2026-02-05 | 837,000 | — | $0 | 837,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-25 | 2025-03-27 | 675,000 | $0.69 | $465.7K | 1,999,296 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-21 | 2025-03-24 | 15,000 | $0.73 | $10.9K | 1,324,296 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-20 | 2025-03-24 | 5,416 | $0.73 | $4.0K | 1,309,296 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-17 | 2025-03-18 | 9,106 | $0.75 | $6.8K | 1,303,880 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-14 | 2025-03-18 | 29,999 | $0.75 | $22.5K | 1,294,774 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-13 | 2025-03-14 | 50,000 | $0.72 | $36.0K | 1,264,775 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2025-03-12 | 2025-03-14 | 47,500 | $0.71 | $33.7K | 1,214,775 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-02-04 | 2025-02-05 | 496,000 | — | $0 | 496,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-31 | 2025-01-03 | 5,000 | $1.21 | $6.0K | 142,553 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-30 | 2025-01-02 | 10,000 | $1.20 | $12.0K | 137,553 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-19 | 2024-12-20 | 6,888 | $0.89 | $6.1K | 127,553 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2024-12-18 | 2024-12-20 | 100,000 | $0.93 | $93.0K | 1,167,275 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-03-01 | 2024-03-04 | 425,000 | — | $0 | 425,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-25 | 2023-05-26 | 900 | $5.31 | $4.8K | 1,067,275 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-24 | 2023-05-26 | 1,000 | $5.01 | $5.0K | 1,066,375 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-23 | 2023-05-25 | 11,856 | $5.63 | $66.7K | 1,065,375 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-02-07 | 2023-02-09 | 330,000 | — | $0 | 330,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2022-12-20 | 2022-12-21 | 19,188 | $5.13 | $98.4K | 120,665 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 327,900 | — | $0 | 327,900 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award | 2021-12-13 | 2021-12-14 | 8,000 | $12.13 | $97.0K | 1,053,519 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-07-20 | 2021-07-22 | 285,800 | — | $0 | 285,800 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 32,876 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 32,876 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 101,477 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-29 | 32,876 | — | $0 | 551,774 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-29 | 32,876 | — | $0 | 551,776 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-29 | 101,477 | — | $0 | 101,477 | SEC↗ |